Sign in
Enrolling by invitationPhase 2

rTMS Target Identification for Functional Disability in AUD+mTBI

Key facts

Who runs it
VA Office of Research and Development
Where
Hines, United StatesSee the site
Trial code
Status
Enrolling by invitation
Phase
Phase 2
People taking part
100 people, planned
Started
1 Jan 2019
Expected to end
31 Mar 2027
Type of study
Interventional, 4 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Magventure MagProX100 with MagOption stimulator and Magpro Cool Coil B65 A/P
Record updated
8 April 2026

Who can take part

Age
22 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Can read and speak English
  • Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria for AUD
  • Symptom Attribution and Classification (SACA) criteria (Pape, Herrold et al 2016, JHTR) for mTBI (without requirement of clinical neuropsychological impairment)

Who cannot take part

  • History of moderate to severe TBI
  • Neurodegenerative disease (e.g., Alzheimer's disease, Parkinson's disease, multiple sclerosis)
  • History of or current psychotic spectrum disorders (i.e., schizophrenia, schizoaffective and bipolar disorders)
  • Meet DSM-5 criteria for moderate to severe cannabis use disorder
  • Contraindications to MRI (e.g., claustrophobia, ferromagnetic metal in eyes or face, congestive heart failure, implanted cardiac pacemaker or defibrillator, cochlear implant, nerve stimulator)
  • Intellectual disability (WTAR predicted full-scale IQ score < 70)42
  • Are pregnant or nursing
  • Use of benzodiazepines, opiates, cocaine, or amphetamines in the past 30 days
  • Meet SACA criteria for 'Questionable Validity' of performance effort and symptom reporting

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 22 and 65 years old?

Where in United States

  • Edward Hines Jr. VA Hospital, Hines, ILHines, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

The objectives of this VA Merit application are to identify a neural target unique to Veterans with co-occurring alcohol use disorder and mild traumatic brain injury (AUD+mTBI) and to test the efficacy of this target as a stimulation site for repetitive transcranial magnetic stimulation (rTMS) treatment to maximize functional recovery. rTMS will soon be a treatment option at 30 VAs nationwide and preliminary studies show promise for AUD and mTBI treatment. A better understanding of how AUD+mTBI impacts the brain needs to occur in order to advance rTMS to optimize function. This research is aligned with the VA RR\&D's mission to generate knowledge and innovations to advance the rehabilitative health and care of Veterans, to effectively integrate clinical and applied rehabilitation research, and translate research results into practice. This research is also aligned with the goal of the Psychological Health \& Social Reintegration portfolio to develop interventions improving psychological health status of Veterans enabling them to function more fully in society.

The 4 groups in the trial

  • Active + Placebo rTMS for Custom Neural Target Group 1Existing treatment, for comparison

    Custom neural anatomical target 1 defined by neuroimaging data

    Treatment: Magventure MagProX100 with MagOption stimulator and Magpro Cool Coil B65 A/P

  • Active + Placebo rTMS for Custom Neural Target Group 2Existing treatment, for comparison

    Custom neural anatomical target 2 defined by neuroimaging data

    Treatment: Magventure MagProX100 with MagOption stimulator and Magpro Cool Coil B65 A/P

  • Active + Placebo rTMS for Custom Neural Target Group 3Existing treatment, for comparison

    Custom neural anatomical target 3 defined by neuroimaging data

    Treatment: Magventure MagProX100 with MagOption stimulator and Magpro Cool Coil B65 A/P

  • Active + Placebo rTMS for Left DLPFC Neural TargetExisting treatment, for comparison

    Neural anatomical target will be the Left Dorsolateral Prefrontal Cortex identified using the 5cm from the motor "hot spot" rule.

    Treatment: Magventure MagProX100 with MagOption stimulator and Magpro Cool Coil B65 A/P

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Neural Target Identification for Functional Disability Associated With Alcohol Related Characteristics Among Veterans With Co-occurring Alcohol Use Disorder and Traumatic Brain Injury
Criteria questions
Built from NCT04043442, who can take part
Publications
Record updated
8 April 2026